Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure

Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure

Aim. To study the impact of a polymorphic variant of the matrix metalloproteinase-3 (MMP-3) gene on the development and course of chronic heart failure (CHF) in patients with coronary heart disease. Subjects and methods. A total of 277 patients with New York Heart Association (NYHA) Functional Class...

Full description

Bibliographic Details
Main Authors:	A T Teplyakov, E N Berezikova, S N Shilov, E V Grakova, Yu Yu Torim, A V Efremov, I D Safronov, M G Pustovetova, R S Karpov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2015-04-01
Series:	Терапевтический архив
Subjects:	heart failure coronary heart disease genetic polymorphism matrix metalloproteinase-3
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31704

Similar Items

Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure
by: A T Tepliakov, et al.
Published: (2013-01-01)

Matrix metalloproteinase 2, 3, and 9 gene polymorphisms in women with rheumatoid arthritis
by: A V Shevchenko, et al.
Published: (2015-12-01)

Classification, regulation of activity, and genetic polymorphism of matrix metalloproteinases in health and disease
by: A. S. Shadrina, et al.
Published: (2017-08-01)

Study of Matrix Metalloproteinase -1 Polymorphism and Susceptibility to Bladder Cancer
by: Delaram Nikfarjam, et al.
Published: (2017-12-01)

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
by: A. O. Rubanenko, et al.
Published: (2018-11-01)

Associations between matrix metalloproteinase gene polymorphisms and glaucoma susceptibility: a meta-analysis
by: Ming-Yue Wu, et al.
Published: (2017-04-01)

Matrix Metalloproteinases and Heart Transplantation—A Pathophysiological and Clinical View
by: Gabriela Patrichi, et al.
Published: (2023-07-01)

Relationship of matrix metalloproteinase-3 -11715A/6A polymorphism (rs35068180) and dilated cardiomyopathy
by: S. Yu. Nikulina, et al.
Published: (2020-11-01)

Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
by: A. V. Shevchenko, et al.
Published: (2023-04-01)

Matrix metalloproteinases polymorphisms as baseline risk predictors in malignant pleural mesothelioma
by: Strbac Danijela, et al.
Published: (2018-02-01)

Gene Polymorphism of Matrix Metalloproteinase 9 in Asthenozoospermic Male Subjects
by: Sina Mohagheghi, et al.
Published: (2018-01-01)

Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis
by: Ling-Feng Wang, et al.
Published: (2013-01-01)

Association of Matrix Metalloproteinases with Coronary Artery Calcification in Patients with CHD
by: Yana V. Polonskaya, et al.
Published: (2021-06-01)

The association of matrix metalloproteinase gene polymorphisms and periodontitis: An overview
by: Dalal H Alotaibi, et al.
Published: (2020-01-01)

Matrix metalloproteinase 9 polymorphism and outcome after myocardial infarction
by: Sophie Rodius, et al.
Published: (2011-07-01)

Polymorphisms of the Matrix Metalloproteinase Genes are Associated with Acute Ischemic Stroke in Chinese Han Population
by: Li A, et al.
Published: (2023-02-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Gender peculiarities and prognostic value of matrix metalloproteinase and their inhibitors system in patients with acute Q-wave left ventricle myocardial infarction
by: S. M. Kyselov
Published: (2015-02-01)

MARKERS OF SYSTEMIC INFLAMMATION AND MATRIX METALLOPROTEINASE / TISSUE INHIBITOR OF METALLOPROTEINASES SYSTEM AT DIFFERENT STAGES OF CHRONIC HEART FAILURE
by: E. N. Egorova, et al.
Published: (2014-07-01)

Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease
by: Alla Vladimirovna Shevchenko, et al.
Published: (2010-03-01)

Association between matrix-metalloproteinase polymorphisms and prostate cancer risk: a meta-analysis and systematic review
by: Zhou H, et al.
Published: (2018-11-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Plasma matrix metalloproteinases in neonates having surgery for congenital heart disease
by: David B. Ross, et al.
Published: (2009-04-01)

How does the Extracellular Matrix Change in the Setting of Heart Failure?
by: Amerikos Argyriou
Published: (2018-12-01)

Features of matrix metalloproteinases MMP2, MMP3, MMP9 genes regulatory region polymorphism in patients with uterine fbroids
by: A. V. Shevchenko, et al.
Published: (2023-04-01)

Genetic Variants of Matrix Metalloproteinase and Sepsis: The Need Speed Study
by: Nicola Fiotti, et al.
Published: (2022-02-01)

The Role of Matrix Metalloproteinases in the Progression and Vulnerabilization of Coronary Atherosclerotic Plaques
by: Opincariu Diana, et al.
Published: (2021-03-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Association of Matrix metalloproteinases-9 -1562 C>T and susceptibility to bladder cancer
by: Mersedeh Rahmani, et al.
Published: (2019-02-01)

Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection
by: Péter Bencsik, et al.
Published: (2018-04-01)

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
by: Luis García-Onrubia, et al.
Published: (2020-08-01)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
by: Merle M. Krebber, et al.
Published: (2020-09-01)

Expression of matrix metalloproteinases 1, 2, 9, 12 in xenogenic tissues of epoxy-crosslinked bioprosthetic heart valves explanted due to dysfunction
by: A. E. Kostyunin, et al.
Published: (2020-11-01)

ASSOCIATION OF MATRIX METALLOPROTEINASES GENE POLYMORPHISM WITH CLINICAL MANIFESTATIONS OF BRONCHIAL ASTHMA IN CHILDREN
by: A. A. Lebedenko, et al.
Published: (2018-12-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
by: Nadezhda Vladimirovna Gaydamaka, et al.
Published: (2009-07-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
by: Igor Yu. Dolmatov, et al.
Published: (2021-09-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)